Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies. (Q48149406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Robert R Luedtke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

26 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

Journal of Labelled Compounds and Radiopharmaceuticals

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

291-298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

Bitropic D3 Dopamine Receptor Selective Compounds as Potential Antipsychotics

28 March 2020

cites work

1 reference

Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors

21 January 2018

1 reference

The dopamine D3 receptor, a quarter century later.

21 January 2018

1 reference

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

21 January 2018

1 reference

Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders

21 January 2018

1 reference

Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease

21 January 2018

1 reference

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

21 January 2018

1 reference

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

21 January 2018

1 reference

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride

21 January 2018

1 reference

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

21 January 2018

1 reference

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors

21 January 2018

1 reference

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo

21 January 2018

1 reference

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.

21 January 2018

1 reference

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy

21 January 2018

1 reference

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

21 January 2018

1 reference

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

21 January 2018

1 reference

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies

21 January 2018

1 reference

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain

21 January 2018

1 reference

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders

21 January 2018

1 reference

Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods

21 January 2018

1 reference

Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist

21 January 2018

1 reference

Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.

21 January 2018

1 reference

Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index

21 January 2018

1 reference

Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor

21 January 2018

1 reference

A series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor

21 January 2018

1 reference

Synthesis and evaluation of fluoro substituted pyridinylcarboxamides and their phenylazo analogues for potential dopamine D3 receptor PET imaging.

21 January 2018

1 reference

In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.

21 January 2018

1 reference

Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study

21 January 2018

1 reference

Interaction of isoflurane with the dopamine transporter

21 January 2018

1 reference

Characterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand

21 January 2018

1 reference

Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.

21 January 2018

1 reference

[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization

21 January 2018

1 reference

Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?

21 January 2018

1 reference

Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates

21 January 2018

1 reference

Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans

21 January 2018

1 reference

A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol

21 January 2018

1 reference

Sweet Dopamine: Sucrose Preferences Relate Differentially to Striatal D2 Receptor Binding and Age in Obesity

21 January 2018

1 reference

Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound

21 January 2018

1 reference

Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist

21 January 2018

1 reference

Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JLCR.3558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857231%20AND%20SRC:MED&resulttype=core&format=json